|
Market Cap (1-Jul) $57,232,348 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 25 November 2021, 12:10. The announcement is marked as price sensitive, and is 21 page(s) in length and 1.42MB in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 665th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| AGM Chairman's Address and Investor Presentation | 25 November 2021, 12:10 |
| FDA advises regulatory pathway for PromarkerD in US | 24 November 2021, 8:12 |
| PromarkerD distribution network expands to Britain | 23 November 2021, 8:11 |
| Initial Directors' Interest Notices | 16 November 2021, 9:41 |
You must be logged in to post a reply.
Proteomics International Laboratories 